InvestorsHub Logo
Followers 6
Posts 256
Boards Moderated 0
Alias Born 05/31/2013

Re: None

Thursday, 09/03/2020 10:29:07 PM

Thursday, September 03, 2020 10:29:07 PM

Post# of 426491
Here is one way out. AMRN works with Teva and H/R to jointly promote Vascepa in US. They split profit with a preset ratio, say 3/1/1/1. Everyone will be happy and we can get half of US. Forward this to JT.

Note this is not the model for just the patented time. This is diamond, which is forever! Do your math, I count >30 billion to AMRN market cap. It will be a better business model than TSLA—-we don’t run out of juice...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News